SARS-CoV-2 – Man-made or natural?

COVID-19 | Best Practice Nordic | 31. Mar 2020 kl. 3:12 | ,,,

Rumors about the origin of the virus SARS-CoV-2 causing COVID-19 are continuously circulating the globe, conspiring about if the virus is a man-made product of genetic manipulation or a lab-escape. In a correspondence article in the online journal Nature Medicine1 these conspiracies are refuted by the comparing of available genome sequence data for known coronavirus ...

Covid-19 – The Search for Effective Therapy

COVID-19 | Best Practice Nordic | 30. Mar 2020 kl. 2:39 | ,

Covid-19 is spreading rapidly in the whole world, but we only have few tools to control the epidemic and treat those who are sick. A combination of the HIV protease inhibitors lopinavir and ritonavir is very promising because it is available, manufacturable and could be prescribed immediately. But does it work against Covid-19? This is ...

Keep up with the mass amount of information about COVID-19 being rolled out online. In this perspective we present three of this week’s COVID-19 headlines from Medscape, The Lancet & The British Medical Journal. Medscape: Is New York City the new Italy? Taking the lead place of most confirmed cases of COVID-19 in the beginning of the week, Italy attracted much attention. However, looking towards the ...

The outbreak of coronavirus disease 2019 (COVID-19) has caused deaths across many countries. However, one country stands out in terms of confirmed cases and a high fatality rate: Italy. With an overall case-fatality rate of 7.2%, Italy has a considerably higher case-fatality rate compared to China at 2.3%. But what are the underlying reasons for ...

The psychological impact of quarantine

COVID-19 | Best Practice Nordic | 25. Mar 2020 kl. 3:30 | ,,

The Lancet has done a literature review in order to uncover the psychological impact of quarantine and isolation1. In this COVID-19 perspective we present some of the key findings from this review and shed light on some of the psychological consequences of infectious diseases and what can be done to diminish these consequences. Quarantine, isolation ...

According to The European Crohn’s and Colitis Organization (ECCO), patients under immunosuppressive/immunomodulatory treatment are not in a significant increased risk of catching COVID-19. As the risk of severe infections is slightly higher in patients under immunosuppression therapies, it is expected that the same might occur in SARS-CoV-2 infections. But data from immunosuppressed patients and SARS-CoV-2 ...

Am I part of the cure, or am I part of the disease

COVID-19 | Jens Lundgren | 23. Mar 2020 kl. 9:28 |

This COVID-19 perspective was produced by Professor Jens D. Lundgren – one of the world’s leading infectious disease specialists. Jens. D. Lundgren is currently leading a clinical trial of investigational vaccine designed to protect against COVID-19. Jens D. Lundgren is also the founder and member of the steering committee of the HIV in Europe Initiative ...

Studies have shown a higher prevalence of severe disease progression with COVID-19 among men – especially Asian men – than in women and in patients of other ethnicities. Furthermore, smokers seem generally more prone to the serious complications of COVID-19 infection, but there is not strong evidence. No firm conclusions can therefore be drawn about ...

This COVID-19 perspective was produced by Professor Jens D. Lundgren – one of the world’s leading infectious disease specialists. Jens. D. Lundgren is currently leading a clinical trial of investigational vaccine designed to protect against COVID-19. Jens D. Lundgren is also the founder and member of the steering committee of the HIV in Europe Initiative ...

Keep up with the mass amount of information about COVID-19 being rolled out online. In this perspective we present three of this week’s COVID-19 headlines from The New England Journal of Medicine, The Lancet & The British Medical Journal. The New England Journal of Medicine: SARS-CoV-2 stability similar to original SARS virus A new study ...

#Siste magasin

BestPractice Nordic

Nr. 1 • mars 2020
1. Årgang
  • Arterosklerotisk sykdom
  • Kreftscreening
  • Depresjon